Charles River Laboratories International Inc. stock underperforms Tuesday when compared to competitors
Shares of Charles River Laboratories International Inc. slipped 3.01% to $145.99 Tuesday, on what proved to be an all-around ...
Marietta Daily Journal1d
Trump says will be 'kind' with tariffs as deadline looms
US President Donald Trump said Monday he would be "very kind" to trading partners when he unveils further tariffs this week, ...
Biotech Stocks Q1 2025 Recap: Winners And Underperformers
Explore Q1 2025's biotech stock moves, from CervoMed's 300% surge to Septerna's struggles. Click for my review of the quarter ...
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE’s Ongoing Clinical Trials for ...
Trump’s promised ‘Liberation Day’ of tariffs is coming. Here’s what it could mean for you
WASHINGTON (AP) — President Donald Trump says Wednesday will be “Liberation Day” — a moment when he plans to roll out a set ...
Grizzlies surprisingly fire Taylor Jenkins, franchise’s winningest coach
Memphis had lost four of five games on its West Coast road trip ahead of a home game Saturday against the Lakers.
Press-Telegram4dOpinion
Protectionism won’t bring back the past or revive old manufacturing jobs
If you believe the political rhetoric, you probably think America’s industrial base has been hollowed out, gutted or “shipped ...
LIXTE Biotechnology Provides Update On Progress with Proprietary Compound, LB-100, to Treat Ovarian and Colorectal Cancer
Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian ...